Inura Medical is a Swiss start-up company with a clear vision to make a difference in women's health. Inura's product is an innovative, first-of-its-kind "intraurethral ovulum" that utilizes a novel route of drug administration to treat diseases of the bladder and lower urinary tract. The first indication we are addressing is a chronic disease, named overactive bladder (OAB). We are located in the HEMEX incubator in Liestal, Switzerland. Inura Medical's technology results from decades of work in urology by Professor S. Grant Mulholland from Jefferson Medical College, Pennsylvania (US). Professor Mulholland was a renowned surgeon, academic, and past President of the American Urology Association. More details on https://inuramedical.ch/.